Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PhRMA Sues To Block 'Unprecedented' California Price Reporting Law

Executive Summary

Ban on WAC price increases violates Commerce Clause and reporting requirement violates First Amendment, PhRMA contends; complaint says state officials have not clarified whether law is retroactive.


Related Content

States Take Center Stage In Tackling Rx Drug Pricing
Nevada Price Transparency Regs Have Trade Secret Safeguards; Industry Drops Lawsuit
Maryland 'Price Gouging' Law's Loss In Court Could Derail Similar Legislation
J&J Stays Within Price Pledge, But Average Doesn't Tell The Whole Story, Analyst Says
Janssen Emphasizes Average Net Price Decline As Transparency Momentum Builds In States
California Enacts Tough Drug Price Reporting Law
Generics Firms Can't Halt Maryland's 'Price Gouging' Law
Nevada Diabetes Drug Pricing Law Targeted By PhRMA/BIO Lawsuit
Rx Data Mining Opponents Will Need New Pitch After Supreme Court Strikes Down Vermont Law


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts